Radiofrequency ablation of hepatic lesions: A review

Applied Radiology

Volumn 32, Issue 10, 2003, Pages 11-26

  Krishnamurthy, Venkataramu N ^a   Casillas, V Javier ^a   Latorre, Lina ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL;

ARTIFICIAL EMBOLISM; BLOOD CLOTTING; CATHETER ABLATION; DEVICE; FOLLOW UP; HISTORY; HUMAN; LAPAROSCOPY; LAPAROTOMY; LIVER CELL CARCINOMA; LIVER INJURY; LIVER METASTASIS; LIVER SURGERY; MONITORING; MORTALITY; OUTCOMES RESEARCH; PATIENT CARE; RETROSPECTIVE STUDY; REVIEW; SURVIVAL RATE;

EID: 0142248419     PISSN: 01609963     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (65)

1. Lau WY. Primary hepatocellular carcinoma. In: Blumgart LH, Fong Y, eds. Surgery of liver and biliary tract. Vol II. 3rd ed. London, UK: WB Saunders; 2000:1423-1450.
2. Nagorney DM, van Heerden JA, Ilstrup D, Adson MA. Primary hepatic malignancy: Surgical management and determinants of survival. Surgery. 1989;106:740-748.
3. Framer DG, Rosove MH, Shaked A, et al. Current treatment modalities for hepatocellular carcinomas. Ann Surg. 1994;219:236-247.
4. Lai EC, Ng IO, Ng MM, et al. Long term results of resection for large hepato cellular carcinoma: A multivariate analysis of clinicopathological factors. Hepatology. 1990;11:815-818.
5. Fong Y, Kemedy N, Paty P, et al. Treatment of colorectal cancer: Hepatic metastases. Semin Surg Oncol. 1996;12:219-252.
6. Bartolozzi C, Lencioli R. Ethanol injection for the treatment of hepatic tumors. Eur Radiol. 1996; 6:682-696.
7. Clouse ME, Lee RG, Duszlak EJ, et al. Peripheral hepatic artery embolization for primary and secondary hepatic neoplasms. Radiology. 1983; 147:407-411.
8. Onik GM, Atkinson D, Zamel R, Weaver ML. Cryosurgery of liver cancer. Semin Surg Onclol. 1993;9:309-317.
9. Murakami R, Yoshimatsu S, Yamashita Y, et al. Treatment of hepatocellular carcinoma: Value of percutaneous microwave coagulation. AJR Am J Roentgenol. 1995;164:1159-1164.
10. Amin Z, Brown SG, Lees WR. Local treatment of colorectal liver metastases: A comparison of interstitial photocoagulation (ILP) and percutaneous alcohol injection (PAI). Clin Radiol. 1993;48:166-171.
11. Chapelon JY, Prat F, Sibille A, et al. Extracorporeal selective focused destruction of hepatic tumors by high intensity ultrasound in rabbits bearing VX-2 carcinoma. Minim Invas Ther. 1992;1:287-293.
12. McGahan JP, Dodd GD III. Radiofrequency ablation of liver. AdR Am J Roentgenol. 2001;176:3-16.
13. Gazelle GS, Goldberg SN, Solbiati L, et al. Tumor ablation with radiofrequency energy. Radiology. 2001;217:633-646.
14. Rossi S, Di Stasi M, Buscarini E, et al. Percutaneous RF interstitial thermal ablation in the treatment of hepatic cancer. AJR Am J Roentgenol. 1996;167:759-768.
15. Solbiati L, Goldberg SN, Ierrace T, et al. Hepatic metastases: Percutaneous radiofrequency ablation with cool tip electrodes. Radiology. 1997;205:367-373.
16. d'Arsonval MA. Action physiologique des courants alternatifs. CR Soc Biol. 1891;43:283-286.
17. Clark WL, Morgan JD, Anisa EJ. Electrothermic methods in treatment of neoplasms and other lesions with clinical and histological observations. Radiology. 1924;2:233-246.
18. Organ LW. Electrophysiologic principles of radiofrequency lesion making. Appl Neurophysiol. 1976;39:69-76.
19. McGahan JP, Browning PD, Brock JM, Tesluk H. Hepatic ablation using radiofrequency electrocautery. Invest Radiol. 1990;25:267-270.
20. Rossi S, Fornari F, Pathies C, Buscarini L. Thermal lesions induced by 480 KHz localized current field in guinea pig and pig liver. Tumori. 1990;76:54-57.
21. Trembley BS, Ryan TP, Strohbehn JW. Interstitial hyperthermia: Physics, biology, and clinical aspects. In: Urano M, Douple E, eds. Physics of Microwave Hyperthermia in Hyperthermia and Oncology. Vol. 3. Utrecht, The Netherlands: Verlag Springer; 1992:11-98.
22. Seegenschmiedt MH, Brady LW, Sauer R. Interstitial thermoradiotherapy: Review on technical and clinical aspects. Am J Clin Oncol. 1990;13:352-363.
23. Goldberg SN, Gazelle GS, Solbiati L, et al. Radiofrequency tissue ablation: Increased lesion diameter with perfusion electrode. Acad Radiol. 1996;3:636-644.
24. Goldberg SN, Solbiati L, Hahn PF, et al. Radiofrequency tumor ablation using a clustered electrode technique: Results in animals and patients with liver metastases. Radiology. 1998;209:371-379.
25. Livraghi T, Goldberg SN, Lazzaroni S, et al. Hepatocellular carcinoma: Radiofrequency ablation of medium and large lesions. Radiology. 2000;214:761-768.
26. Francica G, Marone G. Ultrasound-guided percutaneous treatment of hepatocellular by radiofrequency hyperthermia with a cooled-tip needle: A preliminary clinical experience. Eur J Ultrasound. 1999;9:145-153.
27. Rossi S, Buscarini E, Garbagnati F, et al. Percutaneous treatment of small hepatic tumors by an expandable RF needle electrode. AJR Am J Roentgenol. 1998;170:1015-1022.
28. Cady B, Jenkins RL, Steele GD Jr, et al. Surgical margin in hepatic resection for colorectal metastasis: A crucial and improvable determinant of outcome. Ann Surg. 1998;227:566-571.
29. Goldberg SN, Gazelle SG, Muller PR. Thermal ablation therapy for focal malignancy: A unified approach to underlying principles, techniques, and diagnostic imaging guidance. AJR Am J Roentgenol. 2000;174:323-331.
30. Frank MS, Dodd GD III, Chintapalli KN, Chopra S. Frequent local tumor recurrence after radiofrequency thermal ablation of hepatic tumors: A computer-generated 3-D model for ensuring adequate ablation [abstract]. Radiology. 1999;213(P):509.
31. Goldberg SN, Ahmad M, Gazelle GS, et al. Radiofrequency thermal ablation with adjuvant saline injection: Effect of electrical conductivity on tissue heating and coagulation. Radiology. 2001;219:157-165.
32. McGahan JP, Wer-zhong G, Brock JM, et al. Hepatic ablation using bipolar radiofrequency electrocautery. Acad Radiol. 1996;3:418-422.
33. Goldberg SN, Stein M, Gazelle GS, et al. Percutaneous radiofrequency tissue ablation: Optimization of pulsed-RF technique to increase coagulation necrosis. J Vasc Interv Radiol. 1999;10:907-916.
34. Goldberg SN, Hahn PF, Tanabe KK, et al. Percutaneous radiofrequency tissue ablation: Does perfusion-mediated tissue cooling limit coagulation necrosis? J Vasc Interv Radiol. 1998;9:101-115.
35. Hansen PD, Rogers S, Corless CL, et al. Radiofrequency ablation lesions in pig liver model. J Surg Res. 1999;87:114-121.
36. Goldberg SN, Hahn PF, Halpern E, et al. Radiofrequency tissue ablation: Effect of pharmacologic modulation of blood flow on coagulation diameter. Radiology. 1998;209:761-767.
37. Rossi S, Garbagnati F, Lencioni R, et al. Percutaneous radiofrequency thermal ablation of nonresectable hepatocellular carcinoma after occlusion of tumor blood supply. Radiology. 2000;217:119-126.
38. Curely SA, Izzo F, Delrio P, et al. Radiofrequency ablation of unresectable primary and metastatic hepatic malignancies: Results in 123 patients. Ann Surg. 1999;230:1-8.
39. Cuschieri A, Bracken J, Boni L. Initial experience with laparoscopic ultrasound guided radiofrequency thermal ablation of hepatic tumors. Endoscopy. 1999;31:318-321.
40. Kane RA, Hughes LA, Cua EJ, et al. Impact of intraoperative ultrasonography on surgery for liver neoplasms. J Ultrasound Med. 1994;13:1-6.
41. Goldberg SN, Gazelle GS, Compton CC, et al. Treatment of intrahepatic malignancy with radiofrequency ablation: Radiologic-pathologic correlation. Cancer. 2000;88:2452-2463.
42. Cha CH, Lee FT, Gurney JM, et al. CT versus sonography for monitoring radiofrequency, ablation in a porcine liver. AJR Am J Roentgenol. 2000;175:705-711.
43. Bartolozzi C, Lencioni R, Ricci P, et al. Hepatocellular carcinoma treatment with percutaneous ethanol injection: Evaluation with contrast enhanced color Doppler US. Radiology. 1998;209:387-393.
44. Hosoki T, Mitomo M, Choi S, et al. Visualisation of tumor vessels in hepatocellular carcinoma. Acta Radiol. 1997;38:422-427.
45. Goldberg SN, Walovitch R, Halpern EF, Gazelle GS. Immediate detection of radiofrequency induced coagulation necrosis using a novel ultrasound contrast agent. Radiology. 1999;213:438-444.
46. Choi D, Lim HK, Kim SH, et al. Hepatocellular carcinoma treated with percutaneous radiofrequency ablation: Usefulness of power Doppler US with a microbubble contrast agent in evaluating therapeutic response-preliminary results. Radiology. 2000;217:558-563.
47. Solbiati L, Goldberg SN, Ierace T, et al. Radiofrequency ablation of hepatic metastases: Post procedural assessment with a US microbubble contrast agent-early experience. Radiology. 1999;211:643-649.
48. Dupuy DE, Hong R, Oliver BS, Goldberg SN. Radiofrequency ablation of spinal tumors: Temperature distribution in spinal canal. AJR Am J Roentgenol. 2000;175:1263-1266.
49. Akhurst T, Larson SM. Positron emission tomography imaging of colorectal cancer. Semi Oncol. 1999;26:577-583.
50. Dromain C, De Baere TJ, Elias D, et al. Follow up imaging of liver tumor treated using percutaneous radiofrequency therapy with helical CT and MR imaging [abstract]. Radiology. 1999;213(P):382.
51. Ding H, Kudo M, Onda H, et al. Contrast enhanced subtraction harmonic sonography for evaluating treatment response inpatients with hepatocellular carcinoma. AJR Am J Roentgenol. 2001;176:661-666.
52. Goldberg SN, Dupuy DE. Image guided radiofrequency tumor ablation: Challenges and opportunities-Part I. J Vasc Interv Radiol. 2001;12:1021-1032.
53. Choi H, Loyer EM, DuBrow RA, et al. Radiofrequency ablation of liver tumors: Assessment of therapeutic response and complications. RadioGraphics. 2001;21:S41-S54.
54. Iannitti DA, Dupuy DE, Mayo-smith WW, Murphy B. Hepatic radiofrequency ablation. Arch Surg. 2002;137:422-427.
55. Kainuma O, Asano T, Aoyama H, Shinohara Y. Recurrent hepatocellular carcinoma successfully treated with radiofrequency thermal ablation. Hepatobil Pancr Surg. 1999;6:190-194.
56. Livraghi T, Goldberg SN, Lazzaroni S, et al. Radiofrequency ablation vs. ethanol injection in the treatment of small hepatocellular carcinoma. Radiology. 1999;210:655-661.
57. Curley SA, Izzo F, Ellis LM, et al. Radiofrequency ablation of hepatocellular cancer in 110 patients with cirrhosis. Ann Surg. 2000;232:381-391.
58. de Baere T, Elias D, Dromain C, et al. Radiofrequency ablation of 100 hepatic metastases with a mean follow up of more than 1 year. AJR Am J Roentgenol. 2000;175:1619-1625.
59. Wood TF, Rose DM, Chung M, et al. Radiofrequency ablation of 231 unresectable hepatic tumors: Indications, limitations, and complications. Ann Surg Oncol. 2000;7:593-600.
60. Livraghi T, Goldberg SN, Solbiati L, et al. Percutaneous radiofrequency ablation of liver metastases from breast cancer: Initial experience in 24 patients. Radiology. 2001;220:145-149.
61. Solbiati L, Livraghi T, Goldberg SN, et al. Percutaneous radiofrequency ablation of hepatic metastases from colorectal cancer. Radiology. 2001;221:159-166.
62. Martin LW, Warren RS. Current management of colorectal liver metastases. Surg Oncol Clin North Am. 2000;9:853-878.
63. Lencioni RA, Cioni D, Paolicchi A, et al. Percutaneous treatment of small hepatocellular carcinoma: Radiofrequency ablation versus percutaneous ethanol injection - A prospective, randomized trial (2nd report) [abstract]. Radiology. 1998;209(P):174.
64. Goldberg SN, Saldinger PF, Gazelle G, et al. Percutaneous tumor ablation: Increased coagulation necrosis with combined radiofrequency and percutaneous doxorubicin injection [abstract]. AJR Am J Roentgenol. 2000;174:34.
65. Goldberg SN, Kruskal JB, Oliver BS, et al. Percutaneous tumor ablation: Increased coagulation necrosis by combining radiofrequency ablation and ethanol instillation in a rat breast tumor model. Radiology. 2000;217:827-831.